Locations:
SearchReducing this critical interval is complex, but patients benefit
The time between a cancer diagnosis and the initiation of treatment can be lonely and anxious for patients. Shortening this critical interval is a complicated logistical problem, but benefits patients medically and psychologically, thereby improving outcomes and adding value.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
In this video — part of a series on value-based cancer care — Taussig Cancer Institute Chairman Brian J. Bolwell, MD, FACP, discusses Cleveland Clinic Cancer Center’s commitment to reducing time to treatment.
Click here to view more cancer related videos.
Photo Credit ©Russell Lee
Advertisement
Advertisement
Timing and type of side effects differ greatly from chemotherapy
Dedicated multidisciplinary teams support 84 ultra-rare cancers
Sessions explore treatment advances and multidisciplinary care
New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues
Combination of olaparib and carboplatin results in complete durable response for a patient with BRCA2 and “BRCAness” mutations
Early communication between oncologists and ophthalmologist warranted
Case-based course delves into latest treatment approaches
Long-term relationship building and engagement key to gaining community trust